| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-056 |
| filingDate |
2003-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2006-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2006510645-A |
| titleOfInvention |
Antiviral nucleoside derivatives |
| abstract |
The present invention relates to nucleoside derivatives for treating hepatitis C virus infection comprising compounds of formulas (I) and (II), pharmaceutical compositions comprising these compounds, and diseases mediated by hepatitis C virus. The invention relates to methods for treating or preventing using the above compounds in single therapy or combination therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007505070-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011522784-A |
| priorityDate |
2002-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |